Cephaelis Ipecacuanha

Cephaelis ipecacuanha  (Brot.) A. Rich.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym Psychotria ipecacuanha Stokes.
Family Rubiaceae.
Habitat Native to tropical America. Now cultivated in Darjeeling, Assam, in the Nilgiris, and in Sikkim.
English Ipecac, Ipecacuanha.
Action Root—Antiprotozal, expectorant (in low doses), diaphoretic, emetic (in high doses); used in amoebic dysentery, stubborn cough, whopping cough (for liquefying bronchial phlegm).
Key Application As expectorant, emetic. (The British Herbal Pharmacopoeia.)
Taxonomic Cohort Genus Cephaelis (1 documented species); Family Rubiaceae (40 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Cephaelis ipecacuanha (taxonomically cited with authority (Brot.) A. Rich.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Rubiaceae (primary family classification: Rubiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy Psychotria ipecacuanha Stokes, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Native to tropical America. Now cultivated in Darjeeling, Assam, in the Nilgiris, and in Sikkim.

Across classical and vernacular Indian systems of medicine, Cephaelis ipecacuanha is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Ipecac, Ipecacuanha. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cephaelis ipecacuanha are: Root—Antiprotozal, expectorant (in low doses), diaphoretic, emetic (in high doses); used in amoebic dysentery, stubborn cough, whopping cough (for liquefying bronchial phlegm). These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: As expectorant, emetic. (The British Herbal Pharmacopoeia.).

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Cephaelis ipecacuanha establish the following evidence base: The root contains isoquinoline alkaloids (consisting mainly of emetine and cephaeline); tannins (ipecacuanha and ipecacuanhic acid; glycosides including a monoterpene isoquinoline derivative); saponins; a mixture of glycoproteins; starch; choline; resins. The alkaloids are clinically useful in the treatment of amoebiasis. Emetine and cephaeline are emetic due to their irritating effect on stomach; cephaeline is more toxic. Emetine is a standard antiamoebic principle. In smaller doses, both are expectorant. The fluid extract is 14 times stronger than the syrup of the crude drug. The powder is toxic at 1–2 g. Emetine accumulates in liver, lungs, kidneys and spleen; traces are detectable after 40–60 days. (Francis Brinker.)

In specialized pharmacognostic classifications, Cephaelis ipecacuanha is also listed among standardized commercial herbal extracts used in India with defined quantitative phytochemical markers.

image2

Botanical Reference 1: Carapichea ipecacuanha — Botanical specimen

image3

Botanical Reference 2: Carapichea ipecacuanha — Botanical specimen

image4

Botanical Reference 3: Cephaelis ipecacuanha — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Cephaelis ipecacuanha stands as a distinct representative of the genus Cephaelis. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Rubiaceae encompasses 40 documented medicinal species (2.21% of the 1,814-species flora). Other representative medicinal members of Rubiaceae include: Adina cordifolia (Haridru), Anthocephalus cadamba (Kadamba), Borreria articularis (Madana-ghanti), Canthium parviflorum (Wild Jasmine), Cinchona officinalis (Quinine). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 40 medicinal species of family Rubiaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Cephaelis ipecacuanha follow the plant-part modalities specified under its therapeutic action (Root—Antiprotozal, expectorant (in low doses), diaphoretic, emetic (in high doses); used in amoebic dysentery, stubborn cough, whopping cough (for liquefying bronchial phlegm)), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Cephaelis ipecacuanha integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top